Glucagon-like peptide 1 (7–36) amide (GLP-1) and exendin-4 are gastrointestinal hormones as well as neuropeptides involved in glucose homeostasis and feeding regulation, both peripherally and at the central nervous system (CNS), acting through the same GLP-1 receptor. Aminergic neurotransmitters play a role in the modulation of feeding in the hypothalamus and we have previously found that peripheral hormones and neuropeptides, which are known to modulate feeding in the central nervous system, are able to modify catecholamine and serotonin release in the hypothalamus. In the present paper we have evaluated the effects of GLP-1 and exendin-4 on dopamine, norepinephrine, and serotonin release fromrat hypothalamic synaptosomes, in vitro.We found that glucagon-like peptide 1 (7–36) amide and exendin-4 did not modify either basal or depolarization-induced dopa- mine and norepinephrine release; on the other hand glucagon-like peptide 1 (7–36) amide and exendin-4 stimulated serotonin release, in a dose dependentmanner.We can conclude that the central anorectic effects of GLP-1 agonists could be partiallymediated by increased serotonin release in the hypothalamus, leaving the catecholamine release unaffected.

Glucagon-like-peptide 1 (7-36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus.

BRUNETTI, Luigi;ORLANDO, Giustino;RECINELLA, Lucia;LEONE, Sheila;FERRANTE, CLAUDIO;CHIAVAROLI, Annalisa;LAZZARIN, FRANCESCO;VACCA, Michele
2008

Abstract

Glucagon-like peptide 1 (7–36) amide (GLP-1) and exendin-4 are gastrointestinal hormones as well as neuropeptides involved in glucose homeostasis and feeding regulation, both peripherally and at the central nervous system (CNS), acting through the same GLP-1 receptor. Aminergic neurotransmitters play a role in the modulation of feeding in the hypothalamus and we have previously found that peripheral hormones and neuropeptides, which are known to modulate feeding in the central nervous system, are able to modify catecholamine and serotonin release in the hypothalamus. In the present paper we have evaluated the effects of GLP-1 and exendin-4 on dopamine, norepinephrine, and serotonin release fromrat hypothalamic synaptosomes, in vitro.We found that glucagon-like peptide 1 (7–36) amide and exendin-4 did not modify either basal or depolarization-induced dopa- mine and norepinephrine release; on the other hand glucagon-like peptide 1 (7–36) amide and exendin-4 stimulated serotonin release, in a dose dependentmanner.We can conclude that the central anorectic effects of GLP-1 agonists could be partiallymediated by increased serotonin release in the hypothalamus, leaving the catecholamine release unaffected.
File in questo prodotto:
File Dimensione Formato  
glip1 2008.PDF

Solo gestori archivio

Tipologia: PDF editoriale
Dimensione 318.44 kB
Formato Adobe PDF
318.44 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11564/134303
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 31
social impact